Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis.

Our goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.

Cadenza Bio

Discover our latest 'Why We Invested' blog spotlighting Cadenza Bio, authored by our Analyst, Mansi Patel.  Delve into Cortado Ventures' recent investment in Cadenza Bio, an Oklahoma-based life sciences company revolutionizing therapeutic solutions for demyelinating diseases like multiple sclerosis (MS). Explore the innovative technology behind Cadenza Bio's approach, the unmet medical needs it addresses, and the compelling reasons behind Cortado's investment decision. #investment #lifesciences #multiplesclerosis
 Carol Curtis, Ph.D.  Elaine H. 
 
Read more: https://lnkd.in/gfEE8zfc

"My scientific career has been dedicated to understanding molecular mechanisms mediated through nuclear receptors in disease states. My desire to get novel therapeutics into the marketplace for these diseases has led me to join Cadenza Bio. Here, I get to bridge my love of nuclear receptors with the goal of getting life-changing treatments into the hands of suffering patients." - Jamie Boney-Montoya - Director, Research & Development 

Brain Awareness Week is a worldwide initiative that aims to increase awareness and knowledge about brain research and the progress made in the field of neuroscience. It provides an opportunity to learn more about the intricacies of the brain and how we can sustain its optimal functioning and health. Discover more about how you can participate by visiting: https://lnkd.in/g-Mwprq8

#BrainAwarenessWeek #CadenzaBio #BrainHealth

Raising awareness about Multiple Sclerosis (MS) is immensely important because it helps educate the public about the symptoms, challenges, and impact of this condition. This knowledge can reduce the stigma surrounding MS and promote early diagnosis, leading to timely access to appropriate medical care. Raising awareness can also encourage research and funding for finding better treatments and ultimately a cure for MS. It is essential for fostering empathy, support, and progress in the fight against this debilitating condition. Together, we can make a significant difference. 

#multiplesclerosis #msawareness #chronicillness #cadenzabio

Endometriosis is a chronic condition that affects millions of women worldwide. The exact cause is still unknown, and further research can help uncover potential risk factors and develop more effective treatments. It significantly impacts a person's well-being, so investing in research can improve their quality of life. Raising awareness can combat misinformation and stigma, leading to earlier diagnosis and better support systems. Let us promote accurate information and understanding to empower individuals and foster a compassionate society. To learn more about endometriosis, we recommend watching "Below The Belt: The Last Health Taboo" which can be found here: https://lnkd.in/gDab2BST

#endometriosisawareness #awarenessmonth #endometriosis #cadenzabio

Squarespace Hosted

Co-Founder & CEO

Carol Curtis

Director, Research & Development

Jamie Boney-Montoya

Southern US Companies With Fewer Than 50 Employees (Top 10K)

United States Biotechnology Companies with Seed Funding

Biotechnology Seed Stage Companies With Fewer Than 1000 Employees

United States Startups Founded in 2022

Cadenza Bio accelerates and supports the development of a new class of highly selective Estrogen Receptor targeted small molecules. We are committed to developing therapeutic medications that will improve the lives of patients suffering from terrible diseases.

Plains Ventures

Seed Round - Cadenza Bio

Oklahoma City

Oklahoma

United States

North America

Cadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of Directors

Cadenza Bio on LinkedIn: Cadenza Bio, Inc. Appoints Michael A. Panzara, MD, MPH, to its Board of…

Cadenza Bio, Inc. Secures $2.44M in Oversubscribed Series ...

Rypplzz Raises $3M in Seed Funding

Cadenza Bio Raises $2.44M Series Seed Funding

A novel small molecule compound focused on promoting remyelination and offering neuroprotective and immunomodulatory effects for the treatment of Multiple Sclerosis.

Series of compounds developed for their neuroprotective and immunomodulatory effects, aimed at reversing symptoms and improving motor function in MS.

Ukraine

Europe

Philippines

Asia

Pakistan

Outrun Therapeutics is a preclinical biotechnology company focused on developing therapies for neurodegenerative diseases.

Outrun Therapeutics

Odyssey is a company working on precision therapies for neurodegenerative diseases.

Odyssey

Septerna is focused on developing treatments for neurodegenerative diseases using computational biology and drug development expertise.

Septerna

QurAlis is a company dedicated to developing precision therapies for neurodegenerative diseases.

QurAlis

Nimbus Therapeutics is engaged in the development of therapies for neurodegenerative diseases.

Nimbus Therapeutics

Edesa Biotech is a company focused on developing treatments for neurodegenerative diseases.

Edesa Biotech

Aclaris Therapeutics is involved in the development of therapies for neurodegenerative diseases.

Aclaris Therapeutics

Inotrem is dedicated to developing precision therapies for neurodegenerative diseases.

Inotrem

Denali Therapeutics is a company focused on developing therapies for neurodegenerative diseases.

Denali Therapeutics

Verismo Therapeutics is engaged in the development of precision therapies for neurodegenerative diseases.

Verismo Therapeutics

iECURE is focused on developing precision therapies for neurodegenerative diseases.

iECURE

Transcenta is dedicated to developing treatments for neurodegenerative diseases.

Transcenta

Cadenza is a biotechnology company focused on developing precision therapies for neurodegenerative diseases. The company leverages a combination of computational biology, machine learning, and drug development expertise to identify novel targets and create treatments that can slow or halt disease progression.

news impact assignment basic	general
public peers	general	May 14, 2024 8:30 AM	793c0c8d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	af11ee13
crunchbase profile	general	Nov 25, 2024 9:49 AM	afacaf98
li profile	general	May 14, 2024 8:30 AM	54f6308f
translate crunchbase fundingrounds	general	Nov 25, 2024 2:04 PM	f6354dc0
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:CADENZA

Cadenza